Last reviewed · How we verify
R-3750
At a glance
| Generic name | R-3750 |
|---|---|
| Sponsor | Rise Therapeutics LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- R-3750 in Patients With Mild to Moderate Ulcerative Colitis (PHASE1)
- A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- R-3750 CI brief — competitive landscape report
- R-3750 updates RSS · CI watch RSS
- Rise Therapeutics LLC portfolio CI